News
Wound manager Teratherix has reduced its upcoming IPO from $35m to $25m, citing the need to eliminate 'hot money' on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback